Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Modifying a budget mid-month can be straightforward. Discover simple tweaks and actionable tips to adjust categories while preserving progress.
20,466 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Choosing between EUFN and IAT can shape a portfolio's exposure to the financial sector. This guide breaks down Europe...
As 2026 unfolds, silver and copper lead gains while gold pauses. Three ETFs illustrate how investors are positioning ...
A 72-year-old returns to work after medical bills and rising living costs erode his Social Security, highlighting ris...
In the first half of 2026, ASML delivered a standout rally as AI-driven demand lifted the semiconductor supply chain....
A Supreme Court ruling blocks Trump’s emergency tariffs, leaving executives silent as refunds, labor concerns, and ma...
Costco enters a pivotal earnings season as membership revenue and e-commerce momentum drive potential upside for COST...
Grove Collaborative, trading as GROV, is navigating a challenging yet hopeful path. This article breaks down grove co...
A trio of income funds approaches yields in very different ways, highlighting a key question for retirees: how much u...
Oil markets remain volatile amid geopolitical risk, but three U.S. majors are drawing attention for potential 50%+ re...
Kennametal’s Q3 2026 results shed light on the company’s path through a challenging manufacturing environment. This a...
Tech-focused ETF VGT has rallied strongly, prompting analysts to weigh whether trump’s bull market could push another...